The international team of the start-up Baze has secured 6 million dollars of investment. The funding has been provided by the leading US manufacturer of high-value nutritional supplements Nature’s Way. As startupticker.ch has now reported, Baze is intending to expand its marketing activities and broaden its offering. The company operates branches in Zurich, Berlin and Boston.
Baze is a digital platform for the detection of nutrient deficiencies in the blood. Users can discover if their bodies are lacking any particular nutrients by way of a pain-free blood test. It is carried out in a certified specialist laboratory. Afterwards, the individual values are shared via an app. Moreover, customers receive personalized recommendations for food supplements, which can then be delivered to their homes in the perfect dosage.
The blood test has been developed for the digital health start-up within the framework of an Innosuisse project together with the he University of Applied Sciences of Northwest Switzerland (FHNW). The Massachusetts Institute of Technology also played a part in the development process. The test requires just four drops of blood. Mike Devereux, President and CEO of the new investor Nature's Way, was quoted in the report: “The technology of this produce is a crucial step for the food supplement industry”.
Having been founded back in 2014, the company’s users have grown by 40 percent per month since market introduction. Baze is now intending to make its service available in Europe “in the near future”. Philipp Schulte, Co-Founder and CEO of Baze: “The partnership with Nature’s Way is a fabulous seal of approval. While we will continue to enjoy full independence, their support will greatly help us in making our mission a reality: improving the health of our users over the long term by leveraging evidence-based data to offer personalized nutritional supplement advice”.